相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。KLF7 is associated with poor prognosis and regulates migration and adhesion in tongue cancer
Jiong Lyu et al.
ORAL DISEASES (2022)
Efficacy of immune checkpoint inhibitors in different types of melanoma
Ernesto Rossi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients
Y. Nakamura et al.
ANNALS OF ONCOLOGY (2020)
Head and neck mucosal melanoma: The United Kingdom national guidelines
Pablo Nenclares et al.
EUROPEAN JOURNAL OF CANCER (2020)
Immunotherapy in sinonasal melanoma: treatment patterns and outcomes compared to cutaneous melanoma
Daniella Klebaner et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations
Rong Zhou et al.
CLINICAL CANCER RESEARCH (2019)
Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy
Longwen Xu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Felicity Newel et al.
NATURE COMMUNICATIONS (2019)
Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets
Jiong Lyu et al.
JOURNAL OF PATHOLOGY (2018)
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
Shom Goel et al.
TRENDS IN CELL BIOLOGY (2018)
An update on the current management of head and neck mucosal melanoma
Ben Green et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger et al.
CLINICAL CANCER RESEARCH (2017)
Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases
Jiong Lyu et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis
Joanna H. Tong et al.
CLINICAL CANCER RESEARCH (2016)
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik et al.
CANCER DISCOVERY (2016)
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib A Phase 2 Clinical Trial
Mark A. Dickson et al.
JAMA ONCOLOGY (2016)
Mucosal Melanoma of the Head and Neck: A Systematic Review of the Literature
Stanislav Lazarev et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma
John P. Leonard et al.
BLOOD (2012)
Senescence and immortalization: role of telomeres and telomerase
JW Shay et al.
CARCINOGENESIS (2005)
Establishment and characterization of an oral melanoma cell line (ME)
KW Chang et al.
ORAL ONCOLOGY (2001)
分享论文
